Bictegravir-Induced Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Acute Human Immunodeficiency Virus

Although drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with antiretrovirals, there are no published reports of bictegravir-induced DRESS. Bictegravir is recommended as first-line treatment for patients with human immunodeficiency virus (HIV). Recognition of DRESS, its s...

Descripción completa

Detalles Bibliográficos
Autores principales: DiLorenzo, Madeline A, Medrano, Nicola, Chen, Jason N, Bawany, Fatima, Tran, Duy C, Taunk, Pulkit, Meehan, Shane A, Pomeranz, Miriam Keltz, Mgbako, Ofole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985146/
https://www.ncbi.nlm.nih.gov/pubmed/36879628
http://dx.doi.org/10.1093/ofid/ofad066
Descripción
Sumario:Although drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with antiretrovirals, there are no published reports of bictegravir-induced DRESS. Bictegravir is recommended as first-line treatment for patients with human immunodeficiency virus (HIV). Recognition of DRESS, its skin manifestations, and potential complications is vital for appropriate care and management of acute HIV.

Ejemplares similares